Overview

Update
Acquisitions
8 Acquisitions
IPO / Stock
Went Public on Aug 7, 1987 / NASDAQ:CELG
Headquarters:
Summit, New Jersey
Description:
Celgene discovers, develops and commercializes innovative therapies to treat cancer and immune-inflammatory-related diseases.
Founders:
Categories:
Biotechnology, Medical
Website:
http://www.celgene.com
Social:

Company Details

Update
Founded:
1986
Contact:
+1-908-673-9000
Employees:
10k + | 11 in Crunchbase

Celgene Corporation is a global integrated biopharmaceutical company primarily engaged in the discovery, development and commercialization of innovative therapies designed to treat cancer and immune-inflammatory related diseases in patients with limited treatment options.

There are hundreds of clinical trials at major medical centers evaluating compounds from Celgene. Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma (MM), myelodysplastic syndromes (MDS), chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), pancreatic cancer, non-small lung cancer and melanoma.

In addition, several compounds are being evaluated as therapies for serious inflammatory diseases such as psoriasis and psoriatic arthritis.

DateInvested InRoundPartner(s)
Sep, 2016$70M / Series B
Aug, 2016$37M / Series B
Jul, 2016$57M / Series A
Jul, 2016$22.5M / Series A
May, 2016$10.6M / Series A
May, 2016$46M / Series A (Lead)
Apr, 2016$50M / Series B
Apr, 2016$220M / Series B
Jan, 2016$61.5M / Series A
Dec, 2015$10M / Series C
Apr, 2015$41.8M / Series D
Apr, 2015$64M / Series B
Dec, 2014$38M / Series B
Oct, 2014undisclosed amount / Venture (Lead)
Sep, 2014$50.6M / Series B
Mar, 2014$80M / Series A
Jan, 2014$75M / Venture
Jan, 2014$13.5M / Series B
Dec, 2013$38.5M / Series B
Dec, 2013$26M / Series D
Sep, 2013$25M / Series B (Lead)
Jul, 2013$100M / Private Equity (Lead)
Jul, 2013$33.6M / Series D (Lead)
Feb, 2012$15M / Private Equity
Dec, 2011$30M / Series F (Lead)
Nov, 2011$78M / Series C (Lead)
Jun, 2010$12M / Series B
Jan, 2007$44M / Series C

Current Team (11)

Update

Sub Organizations (2)

Update

Offices/Locations (2)

Update
  • Celgene Corporation

    86 Morris Avenue

    Summit, New Jersey 07901

    United States

  • International Headquarters

    Switzerland – Boudry

    Route de Perreux 1

    Boudry, Neuchatel CH-2017

    Switzerland

Past Team (17)

Update

Images (2)

Update

Add Funding Rounds

Add Products

Add Competitors

Add Memberships

Add Customers

Add Partners

Add Videos